Raphael Pharmaceutical Ratios (2020-2025) | RAPH

Ratios Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Efficiency
Assets Average (Quarter)
0.24M0.30M0.19M0.16M0.23M0.24M0.13M0.26M0.32M0.30M0.24M0.09M0.04M0.06M0.06M0.02M0.03M
Equity Average (Quarter)
-0.17M-0.05M0.03M0.00M0.12M0.11M0.03M0.02M0.05M-0.04M-0.07M0.02M0.00M-0.20M-0.45M-0.68M-0.74M-0.89M-1.16M-1.35M
Invested Capital (Quarter)
-0.30M0.19M-0.12M0.15M0.10M0.13M-0.06M0.11M-0.01M-0.06M-0.07M0.11M-0.10M-0.29M-0.62M-0.70M-0.69M-1.01M-1.22M-1.40M
Leverage & Solvency
Debt to Equity (Quarter)
0.170.010.120.03-0.06-0.06-0.04-0.03-0.02
Debt Ratio (Quarter)
0.050.010.070.011.520.441.375.860.64
Equity Ratio (Quarter)
-2.020.300.570.60-0.510.32-0.06-0.51-0.190.45-0.29-2.27-12.08-27.48-7.89-34.93-180.57-27.04
Valuation
Enterprise Value (Quarter)
-0.04M-0.15M-0.08M-0.14M-0.09M-0.29M-0.04M-0.11M-0.30M-0.23M-0.29M-0.12M-0.04M-0.02M-0.05M-0.02M-0.00M-0.04M
Return Ratios
Return on Capital Employed (Quarter)
3,132.69%-692.86%-1,617.27%11,375.51%-4,121.21%7,048.35%1,156.68%-673.02%975.63%783.66%169.87%206.71%
Return on Assets (Quarter)
-0.07%-0.05%-0.09%-0.18%-0.15%-0.14%-0.24%-0.10%-0.04%-0.05%-0.06%-0.11%-0.39%-0.16%-0.12%-0.21%
Return on Equity (Quarter)
0.21%-0.39%-10.86%-0.13%-0.16%-1.00%-1.51%-0.70%0.92%0.37%-0.80%-7.81%0.07%0.02%0.02%0.01%0.01%0.00%